These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Sporadic late-onset nemaline myopathy in a woman with multiple myeloma successfully treated with lenalidomide/dexamethasone. Montagnese F; Portaro S; Musumeci O; Migliorato A; Moggio M; Fagiolari G; Rodolico C Muscle Nerve; 2015 Jun; 51(6):934-5. PubMed ID: 25524603 [No Abstract] [Full Text] [Related]
64. An overview of the progress in the treatment of multiple myeloma. Kyle RA; Rajkumar SV Expert Rev Hematol; 2014 Feb; 7(1):5-7. PubMed ID: 24433105 [TBL] [Abstract][Full Text] [Related]
65. Necrobiotic xanthogranuloma associated with immunoglobulin m paraproteinemia in a patient with Waldenström macroglobulinemia. Balagula Y; Straus DJ; Pulitzer MP; Lacouture ME J Clin Oncol; 2011 Apr; 29(11):e305-7. PubMed ID: 21245419 [No Abstract] [Full Text] [Related]
67. Necrobiotic xanthogranuloma of the extremities with paraproteinemia and without periorbital involvement at presentation. Hashemi P; Rashidi A; Chapas AM; Balfour EM Cutis; 2012 Jan; 89(1):41-4. PubMed ID: 22439311 [TBL] [Abstract][Full Text] [Related]
68. Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. Bennett CL; Angelotta C; Yarnold PR; Evens AM; Zonder JA; Raisch DW; Richardson P JAMA; 2006 Dec; 296(21):2558-60. PubMed ID: 17148721 [No Abstract] [Full Text] [Related]
69. Treatment of refractory necrobiotic xanthogranulomas with extracorporeal photopheresis and intravenous immunoglobulin. Liszewski W; Wisniewski JD; Safah H; Boh EE Dermatol Ther; 2014; 27(5):268-71. PubMed ID: 24910296 [TBL] [Abstract][Full Text] [Related]
70. Thalidomide and lenalidomide in primary myelofibrosis. Holle N; de Witte T; Mandigers C; Schaap N; Raymakers R Neth J Med; 2010 Aug; 68(1):293-8. PubMed ID: 20739725 [TBL] [Abstract][Full Text] [Related]
71. Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomide. Caers J; Hafraoui K; Keutgens A; Caberg JH; Lambert F; Tassin F; Beguin Y Eur J Haematol; 2014 Feb; 92(2):179-80. PubMed ID: 24299333 [No Abstract] [Full Text] [Related]
73. Transfer factor for the treatment of necrobiotic xanthogranuloma. Tang Z; Ruan J; Cai S Dermatol Ther; 2022 Dec; 35(12):e15894. PubMed ID: 36196500 [No Abstract] [Full Text] [Related]
74. Posterior Scleritis and Necrobiotic Xanthogranuloma. Ali FR; Young HS Ocul Immunol Inflamm; 2016; 24(1):91-2. PubMed ID: 26717063 [No Abstract] [Full Text] [Related]
75. Lenalidomide in myelodysplastic syndromes. List AF Clin Adv Hematol Oncol; 2008 Apr; 6(4):271-2, 311. PubMed ID: 18496493 [No Abstract] [Full Text] [Related]